Article
Derivation of YCMi005-A, a human-induced pluripotent stem cell line, from a patient with dilated cardiomyopathy carrying missense variant in TPM1 (p. Glu192Lys).
Stem cell research - 1 Apr 2022
Cha Yun-Ji, Jeon Sae-Bom, Oh Jaewon, Lee Seung-Tae, Kim Sangwoo, Kim Hyoeun, Choi Jungyoon, Choi Hyo-Kyoung, Won Dongju, Choi Jong Rak, Kim Seok-Jun, Park Sahng Wook, Kang Seok-Min, Lee Seung-Hyun
Abstract excerpt
Dilated cardiomyopathy (DCM) is one of the leading causes of heart transplantation. The clinical feature of DCM is characterized by enlarged heart and impaired function of the left or both ventricles, while its etiology is varied. In this study, we generated YCMi005-A, a human-induced pluripotent stem cell (hiPSC) line from a patient with DCM carrying the missense mutation of p.Glu192Lys in the TPM1 genes....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
